Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 2
2014 3
2015 1
2016 4
2017 3
2018 4
2020 7
2021 9
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.
Chakraborty G, Nandakumar S, Hirani R, Nguyen B, Stopsack KH, Kreitzer C, Rajanala SH, Ghale R, Mazzu YZ, Pillarsetty NVK, Lee GM, Scher HI, Morris MJ, Traina T, Razavi P, Abida W, Durack JC, Solomon SB, Vander Heiden MG, Mucci LA, Wibmer AG, Schultz N, Kantoff PW. Chakraborty G, et al. Among authors: pillarsetty nvk. Clin Cancer Res. 2022 Aug 15;28(16):3603-3617. doi: 10.1158/1078-0432.CCR-21-4272. Clin Cancer Res. 2022. PMID: 35670774 Free PMC article.
Fifty Years of Radiopharmaceuticals.
Brugarolas P, Comstock J, Dick DW, Ellmer T, Engle JW, Lapi SE, Liang SH, Parent EE, Kishore Pillarsetty NV, Selivanova S, Sun X, Vavere A, Scott PJH; Society of Nuclear Medicine and Molecular Imaging Radiopharmaceutical Sciences Council. Brugarolas P, et al. Among authors: kishore pillarsetty nv. J Nucl Med Technol. 2020 Jun;48(Suppl 1):34S-39S. J Nucl Med Technol. 2020. PMID: 32605944 Free article. Review.
Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors - safety at curative doses.
Cheal SM, McDevitt MR, Santich BH, Patel M, Yang G, Fung EK, Veach DR, Bell M, Ahad A, Vargas DB, Punzalan B, Pillarsetty NVK, Xu H, Guo HF, Monette S, Michel AO, Piersigilli A, Scheinberg DA, Ouerfelli O, Cheung NV, Larson SM. Cheal SM, et al. Among authors: pillarsetty nvk. Theranostics. 2020 Sep 14;10(25):11359-11375. doi: 10.7150/thno.48810. eCollection 2020. Theranostics. 2020. PMID: 33052220 Free PMC article.
A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond.
Taldone T, Wang T, Rodina A, Pillarsetty NVK, Digwal CS, Sharma S, Yan P, Joshi S, Pagare PP, Bolaender A, Roboz GJ, Guzman ML, Chiosis G. Taldone T, et al. Among authors: pillarsetty nvk. Cold Spring Harb Perspect Biol. 2020 Apr 1;12(4):a034116. doi: 10.1101/cshperspect.a034116. Cold Spring Harb Perspect Biol. 2020. PMID: 30936118 Free PMC article. Review.
CEACAM5-Targeted Immuno-PET in Androgen Receptor-Negative Prostate Cancer.
Imberti C, De Gregorio R, Korsen JA, Hoang TT, Khitrov S, Kalidindi T, Nandakumar S, Park J, Zaidi S, Pillarsetty NVK, Lewis JS. Imberti C, et al. Among authors: pillarsetty nvk. J Nucl Med. 2024 May 23:jnumed.123.267107. doi: 10.2967/jnumed.123.267107. Online ahead of print. J Nucl Med. 2024. PMID: 38782457
Rapid detection of SARS-CoV-2 using a radiolabeled antibody.
Pirovano G, Ordonez AA, Jain SK, Reiner T, Carroll LS, Pillarsetty NVK. Pirovano G, et al. Among authors: pillarsetty nvk. Nucl Med Biol. 2021 Jul-Aug;98-99:69-75. doi: 10.1016/j.nucmedbio.2021.05.002. Epub 2021 May 25. Nucl Med Biol. 2021. PMID: 34058614 Free PMC article.
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells.
Saha N, Xu K, Zhu Z, Robev D, Kalidindi T, Xu Y, Himanen J, de Stanchina E, Pillarsetty NVK, Dimitrov DS, Nikolov DB. Saha N, et al. Among authors: pillarsetty nvk. Transl Oncol. 2022 Jan;15(1):101265. doi: 10.1016/j.tranon.2021.101265. Epub 2021 Nov 9. Transl Oncol. 2022. PMID: 34768098 Free PMC article.
A dual-modal PET/near infrared fluorescent nanotag for long-term immune cell tracking.
Harmsen S, Medine EI, Moroz M, Nurili F, Lobo J, Dong Y, Turkekul M, Pillarsetty NVK, Ting R, Ponomarev V, Akin O, Aras O. Harmsen S, et al. Among authors: pillarsetty nvk. Biomaterials. 2021 Feb;269:120630. doi: 10.1016/j.biomaterials.2020.120630. Epub 2020 Dec 23. Biomaterials. 2021. PMID: 33395580 Free PMC article.
Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer.
Joshi S, Gomes ED, Wang T, Corben A, Taldone T, Gandu S, Xu C, Sharma S, Buddaseth S, Yan P, Chan LYL, Gokce A, Rajasekhar VK, Shrestha L, Panchal P, Almodovar J, Digwal CS, Rodina A, Merugu S, Pillarsetty N, Miclea V, Peter RI, Wang W, Ginsberg SD, Tang L, Mattar M, de Stanchina E, Yu KH, Lowery M, Grbovic-Huezo O, O'Reilly EM, Janjigian Y, Healey JH, Jarnagin WR, Allen PJ, Sander C, Erdjument-Bromage H, Neubert TA, Leach SD, Chiosis G. Joshi S, et al. Commun Biol. 2021 Nov 25;4(1):1333. doi: 10.1038/s42003-021-02842-3. Commun Biol. 2021. PMID: 34824367 Free PMC article.
38 results